MBL77 - AN OVERVIEW

Not all clients with CLL demand therapy. Even with all current improvements, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic disease.86 This recommendation is based on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Le